Myung In Pharmaceutical LTD. (KOSE: A317450)
Health Care · Pharmaceuticals · KR
₩43,650.00
+3.93% today · -58.9% 1Y
Myung In Pharmaceutical LTD. (KOSE: A317450) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $473.20M.
Over the last twelve months the share price has lost 58.9%, trading between 39.10K and 118.70K.
Tweenvest scores Myung In Pharmaceutical LTD. across four factors: quality 93/100, value 57/100, growth 54/100, dividend 58/100. Its strongest factor is quality.
A317450 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $473.20M
- Revenue (TTM)
- $189.22M
- P/E
- 6.79
- EPS
- 6,428.37
- Dividend yield
- 2.29%
- Beta (5Y)
- —
- 52-week high
- ₩118,700.00
- 52-week low
- ₩39,100.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.60M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PKU HealthCare Corp.,Ltd.SZSE: 000788 | $485.12M | CN¥5.46 | +1.49% |
| Contineum Therapeutics, Inc.NasdaqGS: CTNM | $478.92M | $12.73 | +0.63% |
| Daewoong Co., Ltd.KOSE: A003090 | $478.81M | ₩15,340.00 | -3.46% |
| iX Biopharma Ltd.Catalist: 42C | $478.80M | S$0.56 | +2.75% |
| Dong-A Socio Holdings Co., Ltd.KOSE: A000640 | $472.72M | ₩94,600.00 | +2.16% |
| YungShin Global Holding CorporationTWSE: 3705 | $470.77M | NT$56.30 | +0.54% |
| Vireo Growth Inc.CNSX: VREO | $469.20M | CA$13.70 | -13.84% |
| Shanghai Fudan Forward S&T Co., LtdSHSE: 600624 | $466.89M | CN¥4.61 | -0.22% |
Figures last refreshed Oct 4, 2026.